Doxycycline: An Effective Therapeutic for Acute COVID

It has been demonstrated in the literature, since May 2021 that Doxycycline is an effective and efficacious therapeutic against the SARS-COV2 virus. The literature demonstrates that physiologically Doxycycline works as an antiviral, and anti-inflammatory in a similar fashion to Ivermectin. Adjunctively, Doxycycline is used to boost the antiviral, and anti-inflammatory properties of Ivermectin.

In the literature Doxycycline is dosed at 100 mg twice a day for 10 days, specifically in the papers out of Uttar Pradesh in India, where the Delta mutant was eradicated with Ivermectin and the aforementioned dosing of Doxycycline.

In my protocol, I dose Doxycycline 100 mg twice a day for 5 days, 7 days or 10 days, depending on age of the patient, and pre-existing medical conditions, such as a history of C.difficile and any gut inflammatory diseases, namely Crohn’s disease and Ulcerative colitis, where the microbiome may not tolerate 10 days duration of Doxycycline. In my protocol, Doxycycline is also used in an infected-no symptoms therapeutic regimen for 5 days or 7 days in addition to Ivermectin.

Additionally, in my protocol the patient must take Vitamin D3 10,000 IU, Zinc gluconate/picolinate 200 mg and Magnesium citrate 800mg/400 mg at least 1 hour prior to consuming Doxycycline or Ivermectin for a minimum of 3 weeks, for the efficacy maximization of these drugs, relative to the aforementioned vitamin and micronutrients being used as cofactors for physiological bio-electrochemical operative/catalytic reactions in the body.

Adjunctively, the gut microbiome must be augmented with probiotics such as Lactobacillus Plantarum PS128 for the innate immunity to work effectively, and to minimize or eliminate gut barrier failure secondary to COVID gastroenteritis. An organic, non-GMO, low gluten/no gluten green Mediterranean diet should also be utilized for the exponential optimization of the gut microbiome healing properties.

The most efficient and lean methodology to prevent Long COVID, and the annihilation of decent minimum healthcare access and delivery, is to deploy Telemedicine to the population in the acute phase of COVID infection or symptoms, utilizing Ivermectin and Doxycycline with recent FDA approved antiviral drugs. There must be therapeutic options, since the side effect profile for the recent drugs can have a deleterious effect on the current population, relative to liver and kidney damage. Most Americans cannot afford healthcare, and liver and kidney damage are not adequately assessed in an extremely overweight/obese population, as well as, an alcoholic epidemic which has worsened secondary to isolation during the ongoing pandemic.

Leave a Reply